LY6K promotes glioblastoma tumorigenicity via CAV-1–mediated ERK1/2 signaling enhancement

BACKGROUND: Lymphocyte antigen 6 complex, locus K (LY6K) is a putative oncogene in various cancers. Elevated expression of LY6K is correlated with poor patient prognosis in glioblastoma (GBM). The aim of this study is to advance our understanding of the mechanism by which LY6K contributes to GBM tum...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Sastry, Namratha G, Wan, Xuechao, Huang, Tianzhi, Alvarez, Angel A, Pangeni, Rajendra P, Song, Xiao, James, Charles David, Horbinski, Craig M, Brennan, Cameron W, Nakano, Ichiro, Hu, Bo, Cheng, Shi-Yuan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Basic and Translational Investigations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523463/
https://ncbi.nlm.nih.gov/pubmed/32055849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa032
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia